Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Gaby Inc C.GABY

Alternate Symbol(s):  GABLF

GABY Inc is a retail consolidator and the owner of Mankind Dispensary. Mankind is a well-known, and respected dispensary with deep roots in the California cannabis community operating in San Diego, California. The company curates and sells a diverse portfolio of products, including its own proprietary brands, Lulu's and Kind Republic through Mankind, manufactures Kind Republic, and distributes all its proprietary brands through its wholly owned subsidiary, GABY Manufacturing. A pioneer in the industry with a multi-vertical retail foundation, and a strong management team with experience in retail, consolidation, and cannabis, GABY is poised to grow its retail operations both organically and through acquisition.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (CSE:GABY)

Fundamentals Snapshot (CSE:GABY)

Opinion & Analysis (CSE:GABY)

No current opinion is available.

Bullboard Posts (CSE:GABY)

GABY Inc. Announces a Strategic Acquisition

Highly accretive acquisition of over US$5.4 million of net revenue purchased for CAD$1.3 million payable in GABY common shares...
Betteryear2 - April 28, 2023

Vibe and Gaby should merge

    Vibe Vibe   Gaby ...
lscfa - August 30, 2022

1 billion plus outstanding shares

Thats alot of shares. Way too much dilution. 
Joeking123 - April 13, 2022

Good or bad

I keep waiting for the company to actually make money. These results confuse me
dbottoms - December 1, 2021

Solid Q3 2021 Revenue of $9.5MM

Gross Profit Improved (pro forma, ex Sonoma Pacific Distribution Inc.) to $4.3MM Adjusted EBITDA* improved to $1.9MM SAN DIEGO, CA&...
Betteryear2 - November 24, 2021

🎥📰Anthony Durkacz on Building a Turnaround at FSD Pharma📣

<< View Post To Watch Video >>
Alfonsou - November 18, 2021